Cooper, Mark E.

New-onset diabetes in Covid-19

Rubino, F., Amiel, S. A., Zimmet, P., Alberti, G., Bornstein, S., Eckel, R. H., Mingrone, G., Boehm, B., Cooper, M. E., Chai, Z., et al. (2020) · New England Journal of Medicine

COVID-19 Clinical Research StudiesDiabetes Management and Research

Cited by 801

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Cooper, M. E. (2001) · Diabetologia

Chronic Kidney Disease and DiabetesRenal Diseases and Glomerulopathies

Cited by 375

Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling

Gray, S. P., Di Marco, E., Kennedy, K., Chew, P., Okabe, J., El-Osta, A., Calkin, A. C., Biessen, E. A. L., Touyz, R. M., Cooper, M. E., et al. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology

Nitric Oxide and Endothelin EffectsAtherosclerosis and Cardiovascular Diseases

Cited by 189

Heparanase Is Involved in the Pathogenesis of Proteinuria as a Result of Glomerulonephritis

Levidiotis, V., Freeman, C., Tikellis, C., Cooper, M. E., & Power, D. A. (2004) · Journal of the American Society of Nephrology

Renal Diseases and GlomerulopathiesProteoglycans and glycosaminoglycans research

Cited by 89